CELH Celsius Holdings, Inc.
Celsius Holdings, Inc. develops, processes, manufactures, markets, sells, and distributes functional energy drinks in the United States, North America, Europe, the Asia Pacific, and internationally. The company offers CELSIUS ESSENTIALS, a functional energy drink formulated with aminos; and CELSIUS Hydration, a line of zero-sugar hydration powders featuring electrolytes in various fruit-forward flavors, as well as ready-to-drink energy beverages, on-the-go powder and hydration sticks, and nutrition and wellness products under CELSIUS, Alani Nu, and Rockstar brand names. It distributes its products through direct-to-store delivery, independent distributors, supermarkets, convenience stores, drug stores, nutritional stores, food service providers, and mass merchants, as well as natural food stores, fitness centers, mass market retailers, vitamin specialty stores, club stores, gyms, and e-commerce platforms. The company was formerly known as Vector Ventures, Inc. and changed its name to Celsius Holdings, Inc. in January 2007. Celsius Holdings, Inc. was founded in 2004 and is headquartered in Boca Raton, Florida.…
Industry Peers
Beverages - Non-AlcoholicKey Statistics
About Celsius Holdings (NASDAQ: CELH)
›
Celsius Holdings (NASDAQ: CELH) is listed on Nasdaq, where its shares trade in USD. It belongs to the Beverages - Non-Alcoholic industry, part of the Consumer Defensive sector, and reports about 1,497 employees.
The shares were at 30.72 USD on 19 November 2026, down 31.8% over 52 weeks. Its 52-week range is 23.55 USD to 59.31 USD: the price is 48.2% below the high and 30.4% above the low.
At a market capitalisation of 7.70B USD, it trades at 34.5 times trailing earnings and 18.4 times forward earnings. The median trailing P/E of its 20 largest Beverages - Non-Alcoholic peers is 22.5, a premium of 53% for CELH.
Celsius Holdings reports return on equity of 3.7%, an operating margin of 20.6% and revenue up 16.8% year over year.
It holds more cash than debt, a net cash position of 25.91M USD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 21 analysts cover the stock, with an average rating of Buy; their mean price target of 41.59 USD is 35.4% above the current price. The next earnings report is expected on 25 February 2027.